Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Navidea Biopharmaceuticals Inc NAVB

Healthcare Biotechnology
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of undetected disease. The Company’s business is focused on... see more

Recent & Breaking News (GREY:NAVB)

Navidea and Macrophage Therapeutics to Provide Business Update

Business Wire April 15, 2016

Navidea Updates Clinical Development Plan for Diagnostic Use of Lymphoseek® IV in Rheumatoid Arthritis

Business Wire April 4, 2016

Navidea Announces Fourth Quarter and Full Year 2015 Results

Business Wire March 23, 2016

Navidea Biopharmaceuticals to Announce Fourth Quarter and Full Year 2015 Results on March 23, 2016

Business Wire March 21, 2016

Navidea Biopharmaceuticals Announces Delay in Filing of Form 10-K

Business Wire March 14, 2016

Navidea and Platinum Enter Into Agreement Reaffirming Loan Obligations and Agreeing to Standstill Provisions

Business Wire March 14, 2016

Navidea Biopharmaceuticals Enrolls First Patient in Cervical Cancer Study of Lymphoseek®

Business Wire February 11, 2016

Navidea Biopharmaceuticals to Present at 2016 BIO CEO & Investor Conference

Business Wire February 4, 2016

Navidea Provides Update on Lymphoseek® and Immunodiagnostics Development Pipeline

Business Wire February 2, 2016

Navidea Meets Guidance With 2015 Unaudited Lymphoseek® Sales of $10.2 Million

Business Wire January 11, 2016

Navidea Appoints Anton Gueth Chairman of the Board

Business Wire January 11, 2016

Navidea Biopharmaceuticals Enrolls First Patient in Pediatric Trial of Lymphoseek®

Business Wire January 6, 2016

Navidea Biopharmaceuticals to Present at Biotech Showcase 2016

Business Wire January 4, 2016

Lymphoseek® Technically Successful in Evaluation of Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy

Business Wire December 10, 2015

Lymphoseek® Reduces Sentinel Lymph Node Biopsy Imaging Time, Facilitating Patient Throughput and Workflow Efficiencies

Business Wire December 3, 2015

Direction of Market Influences - Research on Enova International, Navidea Biopharmaceuticals, Peabody Energy and Tucows

Accesswire November 18, 2015

Navidea Biopharmaceuticals to Present at Stifel 2015 Healthcare Conference

Business Wire November 10, 2015

Navidea Reports 2015 Third Quarter Financial Results

Business Wire November 4, 2015

Navidea Biopharmaceuticals to Announce Third Quarter 2015 Financial Results on November 4, 2015

Business Wire October 26, 2015

Navidea Biopharmaceuticals to Present at BIO Investor Forum

Business Wire October 14, 2015